| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 贸易(元) | 2,224,356,858.79 | 1,093,339,267.48 | 4,366,610,471.84 | 2,392,175,657.86 |
| 制剂(元) | 1,675,790,478.84 | 1,336,857,915.28 | 1,696,488,472.12 | 1,351,450,377.50 |
| 原药(元) | 7,383,501,261.16 | 4,515,173,062.69 | 9,490,189,292.60 | 5,667,171,319.38 |
| 其他主营业务(元) | - | - | - | 154,486,481.62 |
| 其他(元) | 1,610,660.16 | 121,194,363.66 | 1,919,452.42 | 154,486,481.62 |
| 营业成本(元) | ||||
| 贸易(元) | 2,002,717,568.89 | - | 4,108,412,980.96 | - |
| 制剂(元) | 1,216,853,482.03 | - | 898,180,945.01 | - |
| 原药(元) | 5,156,847,047.88 | - | 6,497,890,168.81 | - |
| 其他主营业务(元) | - | - | - | - |
| 其他(元) | 1,155,411.97 | - | 1,359,825.46 | - |
| 毛利(元) | ||||
| 贸易(元) | 221,639,289.90 | - | 258,197,490.88 | - |
| 制剂(元) | 458,936,996.81 | - | 798,307,527.11 | - |
| 原药(元) | 2,226,654,213.28 | - | 2,992,299,123.79 | - |
| 其他主营业务(元) | - | - | - | - |
| 其他(元) | 455,248.19 | - | 559,626.96 | - |
| 毛利率(%) | ||||
| 贸易(%) | 9.96 | - | 5.91 | - |
| 制剂(%) | 27.39 | - | 47.06 | - |
| 原药(%) | 30.16 | - | 31.53 | - |
| 其他主营业务(%) | - | - | - | - |
| 其他(%) | 28.26 | - | 29.16 | - |
| 收入构成(%) | ||||
| 贸易(%) | 19.71 | 15.47 | 28.07 | 24.61 |
| 制剂(%) | 14.85 | 18.92 | 10.91 | 13.90 |
| 原药(%) | 65.43 | 63.89 | 61.01 | 58.31 |
| 其他主营业务(%) | - | - | - | 1.59 |
| 其他(%) | 0.01 | 1.72 | 0.01 | 1.59 |
| 毛利构成(%) | ||||
| 贸易(%) | 7.62 | - | 6.38 | - |
| 制剂(%) | 15.78 | - | 19.71 | - |
| 原药(%) | 76.58 | - | 73.90 | - |
| 其他主营业务(%) | - | - | - | - |
| 其他(%) | 0.02 | - | 0.01 | - |